Keywords: HCC; CHD; coronary heart disease; COX-2; cyclooxygenase-2; DIO; diet-induced obesity; GFR; glomerular filter rate; HMG Co-A; hydroxymethyl glutaryl-CoA; HCC; hepatocellular carcinoma; IL-1β; interleukin-1 β; iNOS; inducible nitic oxide synthase; LDL-C; low d
مقالات ISI HCC (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: HCC; Hepatic artery embolization; learning curve; hepatocellular carcinoma; operator experience; TAE; Transarterial hepatic embolization; TACE; Transarterial chemoembolization; HCC; Hepatocellular carcinoma; OS; Overall survival; TLP; Time to local tumor progr
Keywords: HCC; AFP; α-fetoprotein; HCC; hepatocellular carcinoma;
Keywords: HCC; Armed Forces Institute of Pathology; AFIP; Continuing medical education; CME; College of Pathologists Pakistan; CPP; Medical laboratory technologists; MLTs; Pakistan Association of Medical Laboratory Sciences; PAMLS; Medical Laboratory Technologist Associ
Keywords: HCC; WHC-17; Woodchuck; Mitochondria; Cinnamic; Sinapic; Ferullic; CA; caffeic acid; FA; ferulic acid; HCC; hepatocellular carcinoma; ECAR; extra cellular acidification rate; TAE; transarterial embolization; FBS; fetal bovine serum; DMSO; dimethylsulfoxide; PB
Keywords: HCC; AFP; alpha-fetoprotein; AFP-L3; Lens culinaris agglutinin-reactive AFP isoform 3; CECT; contrast-enhanced computed tomography; HCC; hepatocellular carcinomaPIVKA-II - proteins induced by vitamin K absence or antagonist-II; PV; portal vein; PVL; portal v
Keywords: HCC; AMPK; AMP-activated protein kinase; ARF6; ADP-ribosylation factor 6; AKT; protein kinase B; BBB; blood brain barrier; bFGF; b-fibroblast growth factors; b-FGFR; b-fibroblast growth factors receptor; ccRCC; clear cell renal cell carcinoma; ECs; endothelial
Keywords: HCC; BoNT; botulinum neurotoxins; TeNT; tetanus toxin; LC; light chain of botulinum neurotoxins; HC; heavy chain of botulinum neurotoxins; HCN; translocation domain of botulinum neurotoxins; HCC; receptor binding domains of botulinum neurotoxins; LD50; half-le
Keywords: HCC; Glucocerebrosidase deficiency; Lysosomal storage disease; Resting energy expenditure; Insulin resistance; High-density lipoprotein cholesterol; Hepatocellular carcinoma; Gaucher disease; ApoAI; apolipoprotein AI; ApoB; apolipoprotein B; ApoE; apolipoprote
Keywords: HCC; BAT; bolus arrival time; CHA; common hepatic artery; DSA; digital subtraction angiography; HCC; hepatocellular carcinoma; IQR; interquartile range; PHA; proper hepatic artery; QCA; quantitative color-coding analysis; 3D; three-dimensional; 2D; two-dimensi
Keywords: HCC; AFD; automated feeder detection; DSA; digital subtraction angiography; HCC; hepatocellular carcinoma; MA; manual adjustment;
Keywords: HCC; CI; confidence interval; FLR; future liver remnant; HCC; hepatocellular carcinoma; IQR; interquartile range; PVE; portal vein embolization; TLV; total liver volume; 90Y; yttrium-90;
Keywords: HCC; Hepatocellular carcinoma (HCC); Percutaneous liver biopsy; Imaging guidance; Diagnostic yield; Efficacy study; AASLD; American Association for the Study of Liver Diseases; CT; Computed Tomography; EASL; European Association for the Study of the Liver; HCC
Keywords: HCC; CG; Cholyglycine; FPIA; fluorescence polarization immunoassay; EMIT; enzyme multiplied immunoassay technique; HCC; hepatocellular carcinoma; EDF; fluoresceinthiocarbamyl ethylenediamine; FP; fluorescence polarization; LOD; limit of detection; CR; cross-re
Keywords: HCC; AGEs; advanced glycation end products; CEL; Nε-(carboxyethyl) lysine; CMA; NÏ-(carboxymethyl) arginine; CML; Nε-(carboxymethyl) lysine; H2O2; hydrogen peroxide; HCC; hepato-cellular carcinoma-; HMGB1; high mobility group box-1; NAFLD; nonalcoholic fatt
Keywords: HCC; HCC; hepatocellular carcinoma; PVA; polyvinyl alcohol; RIPA; right inferior phrenic artery; 90Y; yttrium-90;
Keywords: HCC; Extracellular vesicles; Exosomes; Liver; NAFLD; NASH; HCC;
Keywords: HCC; Hepatocellular carcinoma; Nomogram; Time-dependent receiver operating characteristics; Prognostic prediction; ALBI; Albumin-bilirubin; ALT; Alanine transaminase; ANN; Artificial neural network; AST; Aspartate transaminase; BCLC; The Barcelona Clinic Liv
Keywords: HCC; CR; complete response; DEE; drug-eluting embolic; ÎPBV; change in median parenchymal blood volume; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PBV; parenchymal blood volume; PD; progressive disease; PR;
Keywords: HCC; AI; Artificial Intelligence; HCC; hepatocellular carcinoma; ML; machine learning; qEASL; quantitative European Association for the Study of the Liver;
Keywords: HCC; CI; confidence interval; CR; complete response; DEE; drug-eluting embolic; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PEG; polyethylene glycol; PR;
Keywords: HCC; HCC; hepatocellular carcinoma; 125I; iodine-125; MPV; main portal vein; OS; overall survival; PVTT; portal vein tumor thrombus; SMV; superior mesenteric vein;
Keywords: HCC; Liver surgery; Laparoscopy; Hospital stay; Complication; Meta-analysis; CRD42017058124; LH; laparoscopic hepatectomy; OH; open hepatectomy; RCTs; randomized controlled trials; CNKI; China National Knowledge Infrasture; ASA; American Society of Anesthesiol
Keywords: HCC; ABC; ATP-binding cassette; ASBT; apical sodium-dependent bile acid transporter; Bamet-UD2; cisplatin-ursodeoxycholic acid derivative; CCA; cholangiocarcinoma; DHMEQ; dehydroxymethyl epoxyquinomicin; EGFR; epidermal growth factor receptor; 5-FU; 5-fluorour
Keywords: HCC; AST; aspartate aminotransferase; HCC; hepatocellular carcinoma; LRT; locoregional therapy; MRE; magnetic resonance elastography; OCM; Oncopig Cancer Model;
Keywords: HCC; CI; confidence interval; HCC; hepatocellular carcinoma; HR; hazard ratio; MELD; Model for End-stage Liver Disease; NCDB; National Cancer Database; OS; overall survival; SR; surgical resection;
Keywords: HCC; Big Data; GeneCF; GPC; HCC; Recommender systems; Collaborative filtering;
Keywords: HCC; 2,5-DXP; 2,5-diketopiperazine; ACC; adenoid cystic carcinomas; BBR; berberine; BET; bromodomain and extraterminal; CA; chebulagic acid; CPT; camptothecin; EMT; epithelial-mesenchymal transition; GSK3; glycogen synthase kinase 3-; HCC; hepatocellular carci
Keywords: HCC; Krüppel-like factor 4; Meta-analysis; Prognosis; Cancer; Tumor; Carcinoma; TNBC; triple-negative breast cancer; BC; breast cancer; CRC; colorectal cancer; ESCC; esophageal squamous cell carcinoma; GC; gastric cancer; HCC; hepatocellular carcinoma; NPC; n
Keywords: HCC; HCC; hepatocellular carcinoma; ICBs; immune checkpoint blockades; DMSO; dimethyl sulfoxide; PCR; polymerase chain reaction; VEGF; vascular endothelial growth factor; FGF; fibroblast growth factor; PDGF; platelet derived growth factor; Hepatocellular carci
Keywords: HCC; Pattern-recognition receptors (PRRs); Toll-like receptors (TLRs); RIG-I-like receptors (RLRs); NOD-like receptors (NLRs); Small molecule modulators; BIR; baculovirus inhibitor repeat; CARD; caspase recruitment domains; CFS; chronic fatigue syndrome; CLR;
Keywords: HCC; Aflatoxin; Hepatocarcinogen; HCC; Bibliometry; Global publication output;
Keywords: HCC; aHSC; activated hepatic stellate cells; rHSC; reverted hepatic stellate cells; qHSC; quiescent hepatic stellate cells; MSCs; mesenchymal stem cells; IL-1β; interleukin-1β; IL-2; interleukin-2; IL-6; interleukin-6; IL-8; interleukin-8; TGF-β; transformi
Keywords: HCC; CI; confidence interval; ESD; endoscopic submucosal dissection; HCC; hepatocellular carcinoma; HR; hazard ratio;
Keywords: HCC; HNE; 4-hydroxynonenal; NMR; nuclear magnetic resonance; MS; mass spectrometry; LC-MS; liquid chromatography-mass spectrometry; GC-MS; gas chromatography-mass spectrometry; CE-MS; capillary electrophoresis-mass spectrometry; MALDI-IMS; matrix-assisted lase
Keywords: HCC; AE; adverse event; AUC; area under the curve; CI; confidence interval; Cmax; maximum concentration; HCC; hepatocellular carcinoma; HR; hazard ratio; OS; overall survival; PK; pharmacokinetic; PVA; polyvinyl alcohol; TTP; time to progression; W/O; water-in
Keywords: HCC; AR; Amphiregulin; ChIP; Chromatin immunoprecipitation; CM; Conditional medium; EMT; Epithelial-mesenchymal transition; Endostatin; Collagen XVIII; HCC; Hepatocellular carcinoma; HUVEC; Human umbilical vein endothelial cell; IGFBP-3; Insulin-like growth fa
Keywords: HCC; Thyroid hormone; Liver cancer; Tumor microenvironment; Liver fibrogenesis; ALT; alanine amino transferase; BBC; basal cell carcinoma; CCL4; carbontetrachloride; CD; choline-deficient; CDK2; cyclin-dependent kinase; CSC; cancer stem cell; DKK; dickkopf Wnt
Keywords: HCC; DEE; drug-eluting embolic; FdUrd-C8; 3â²,5â²-dioctanoyl-5-fluoro-2â²-deoxyuridine; HCC; hepatocellular carcinoma; IL; interleukin; LRT; locoregional therapy; MN-16ET; N-[2-(triphenylmethyl)thioethyl]-3-aza-19-ethyloxycarbonyl-3-[2-(triphenylmethyl)thio
Keywords: HCC; ATP; Adenosine 5c-triphosphate; ALT; Alanine aminotransferase; aa; Amino acid; ASK1; Apoptosis signal- regulating kinase 1; AST; Aspartate aminotransferase; BASH; Both alcoholic and non-alcoholic liver disease; CCR2/CCR5; C-C chemokine receptor types 2 an
Keywords: HCC; CTGF; connective tissue growth factor; Col-I; collagen type-I; EMT; epithelial-mesenchymal transition; HCC; hepatocellular carcinoma; HSCs; hepatic stellate cells; TGF-β1; transforming growth factor beta1; TME; tumor microenvironment;
Keywords: HCC; Metabolic diseases; Lipids; Glycogen; Fenofibrate; AST; aspartate transaminase; ALT; alanine transaminase; CKD; Chronic Kidney Disease; EMT; epithelial-mesenchymal transition; G6P; glucose-6 phosphate; G6Pase; glucose-6 phosphatase; GSDI; Glycogen Storage
Keywords: HCC; Label-free cells; Capture and concentration; Stem cells; Cancer stem cells (CSCs); Circulating tumor cells (CTCs); ABC transporter; adenosine triphosphate-binding cassette transporter; BCRP; breast cancer resistance protein; CKs; cytokeratins; CSCs; cance
Keywords: HCC; Liver; Proliferation; Cancer; Tumor-Suppressor Proteins; Progenitor Cells; BrdU; bromodeoxyuridine; cDNA; complementary DNA; C/EBP; CCAAT/enhancer binding protein; Co-IP; co-immunoprecipitation; CUGBP1; CUG triplet repeat binding protein 1; DEN; diethylni
Keywords: HCC; Surveillance; Survival; Liver Cancer; Liver Transplantation; AASLD; American Association for the Study of Liver Diseases; AFP; α-fetoprotein; CAPRI; Compensation and Pension Record Interchange; CI; confidence interval; CDW; Corporate Data Warehouse (Vete
Keywords: HCC; Nucleoskeleton; Envelopathies; Progeria; Myopathy; Neuropathy; Lipodystrophy; Nonalcoholic Fatty Liver Disease; BANF1; barrier to autointegration factor; EDMD; Emery-Dreifuss muscular dystrophy; FTI; farnesyl transferase inhibitor; FPLD2; type 2 (Dunnigan
Keywords: HCC; FK228 (PubChem CID: 5352062); PXD101 (PubChem CID: 6918638); SAHA (PubChem CID: 5311); LBH-589 (PubChem CID: 6918837); tubacin (PubChem CID: 6675804); tubastatin A (PubChem CID: 49850262); ACY-1215 (PubChem CID: 53340666); ACY-241 (PubChem CID: 53340426);
Keywords: HCC; Liver Cancer; Screening; Early Detection; Curative Treatment; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; IPCW; inverse probability of censoring weighted; IQR
Keywords: HCC; GEO; HCC; Prognostic signature; Survival; TCGA;
Keywords: HCC; AALDLT; adult-to-adult living donor liver transplantation; CLD; chronic liver disease; DDLT; deceased donor liver transplantation; EAD; early allograft dysfunction; GRWR; graft-to-recipient weight ratio; HAT; hepatic artery thrombosis; HBV; hepatitis B vi